Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.

about

Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.

Item

http://www.wikidata.org/entity/Q47102409

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.

@en

Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.

@nl

type

Item

label

Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.

@en

Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.

@nl

prefLabel

Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.

@en

Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.

@nl

P1476

Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.

@en

P2093

Joshua A Cohen

http://www.w3.org/2001/XMLSchema#string

Moussa Mansour

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.

Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor M

Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation.

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis

Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).

Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation.

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.

Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.

Long-term outcome of catheter ablation in patients with atrial fibrillation originating from nonpulmonary vein ectopy.

P304

1490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.4022/JAFIB.1490

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29250255

http://www.w3.org/2001/XMLSchema#string

P921

catheter ablation

P932

5673314

http://www.w3.org/2001/XMLSchema#string